node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
igf1 | igf1ra | ENSDARP00000017449 | ENSDARP00000017066 | Insulin-like growth factor 1b. | Tyrosine-protein kinase receptor. | 0.977 |
igf1 | igf1rb | ENSDARP00000017449 | ENSDARP00000046541 | Insulin-like growth factor 1b. | Tyrosine-protein kinase receptor. | 0.979 |
igf1 | igfbp1a | ENSDARP00000017449 | ENSDARP00000135671 | Insulin-like growth factor 1b. | Insulin-like growth factor-binding protein 1a. | 0.919 |
igf1 | igfbp2a | ENSDARP00000017449 | ENSDARP00000068816 | Insulin-like growth factor 1b. | Insulin-like growth factor-binding protein 2-A; IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. | 0.894 |
igf1 | igfbp3 | ENSDARP00000017449 | ENSDARP00000135216 | Insulin-like growth factor 1b. | Insulin-like growth factor-binding protein 3. | 0.955 |
igf1 | igfbp5b | ENSDARP00000017449 | ENSDARP00000054136 | Insulin-like growth factor 1b. | Insulin-like growth factor-binding protein 5b. | 0.834 |
igf1 | ins | ENSDARP00000017449 | ENSDARP00000051221 | Insulin-like growth factor 1b. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.979 |
igf1 | insb | ENSDARP00000017449 | ENSDARP00000115146 | Insulin-like growth factor 1b. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.926 |
igf1 | insra | ENSDARP00000017449 | ENSDARP00000023951 | Insulin-like growth factor 1b. | Tyrosine-protein kinase receptor. | 0.928 |
igf1 | insrb | ENSDARP00000017449 | ENSDARP00000096601 | Insulin-like growth factor 1b. | Tyrosine-protein kinase receptor. | 0.937 |
igf1ra | igf1 | ENSDARP00000017066 | ENSDARP00000017449 | Tyrosine-protein kinase receptor. | Insulin-like growth factor 1b. | 0.977 |
igf1ra | igf1rb | ENSDARP00000017066 | ENSDARP00000046541 | Tyrosine-protein kinase receptor. | Tyrosine-protein kinase receptor. | 0.906 |
igf1ra | igfbp1a | ENSDARP00000017066 | ENSDARP00000135671 | Tyrosine-protein kinase receptor. | Insulin-like growth factor-binding protein 1a. | 0.414 |
igf1ra | igfbp3 | ENSDARP00000017066 | ENSDARP00000135216 | Tyrosine-protein kinase receptor. | Insulin-like growth factor-binding protein 3. | 0.415 |
igf1ra | igfbp5b | ENSDARP00000017066 | ENSDARP00000054136 | Tyrosine-protein kinase receptor. | Insulin-like growth factor-binding protein 5b. | 0.492 |
igf1ra | ins | ENSDARP00000017066 | ENSDARP00000051221 | Tyrosine-protein kinase receptor. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.985 |
igf1ra | insb | ENSDARP00000017066 | ENSDARP00000115146 | Tyrosine-protein kinase receptor. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.984 |
igf1ra | insra | ENSDARP00000017066 | ENSDARP00000023951 | Tyrosine-protein kinase receptor. | Tyrosine-protein kinase receptor. | 0.555 |
igf1ra | insrb | ENSDARP00000017066 | ENSDARP00000096601 | Tyrosine-protein kinase receptor. | Tyrosine-protein kinase receptor. | 0.579 |
igf1rb | igf1 | ENSDARP00000046541 | ENSDARP00000017449 | Tyrosine-protein kinase receptor. | Insulin-like growth factor 1b. | 0.979 |